112 related articles for article (PubMed ID: 11401483)
21. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
[TBL] [Abstract][Full Text] [Related]
22. A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception.
Pelegrini-da-Silva A; Martins AR; Prado WA
Neuroscience; 2005; 132(2):453-63. PubMed ID: 15802196
[TBL] [Abstract][Full Text] [Related]
23. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
24. The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis.
Papademetriou V
J Hum Hypertens; 2002 Aug; 16 Suppl 3():S34-41. PubMed ID: 12140726
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
He M; He X; Xie Q; Chen F; He S
Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF
Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA
Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314
[TBL] [Abstract][Full Text] [Related]
29. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
30. Effect of compound EXP-2528 on angiotensin II-induced E-selectin and VCAM-1 expression in rat brain microvascular endothelial cells in vitro.
Liu HQ; Wei XB; Lou HY; Zhang B; Sun R; Zhang XM
Yao Xue Xue Bao; 2007 Aug; 42(8):822-7. PubMed ID: 17944228
[TBL] [Abstract][Full Text] [Related]
31. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Mar; 31(3):575-84. PubMed ID: 18497479
[TBL] [Abstract][Full Text] [Related]
32. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
Lee CH; Jeong TS; Choi YK; Hyun BH; Oh GT; Kim EH; Kim JR; Han JI; Bok SH
Biochem Biophys Res Commun; 2001 Jun; 284(3):681-8. PubMed ID: 11396955
[TBL] [Abstract][Full Text] [Related]
33. Expression of cytokine genes in the aorta is altered by the deficiency in MCP-1: effect of a high-fat, high-cholesterol diet.
Rull A; Beltrán-Debón R; Aragonès G; Rodríguez-Sanabria F; Alonso-Villaverde C; Camps J; Joven J
Cytokine; 2010 May; 50(2):121-8. PubMed ID: 20207162
[TBL] [Abstract][Full Text] [Related]
34. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits.
Chen H; Li D; Mehta JL
J Cardiovasc Pharmacol; 2002 Mar; 39(3):332-9. PubMed ID: 11862111
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation.
Piqueras L; Kubes P; Alvarez A; O'Connor E; Issekutz AC; Esplugues JV; Sanz MJ
Circulation; 2000 Oct; 102(17):2118-23. PubMed ID: 11044430
[TBL] [Abstract][Full Text] [Related]
36. Involvement of enhanced coagulation and fibrinolysis system in induction of atherosclerosis in hyperlipidemic rabbits fed on a high cholesterol diet.
Ichino K; Okazaki M; Usami S; Oguchi K
In Vivo; 1997; 11(2):115-23. PubMed ID: 9179603
[TBL] [Abstract][Full Text] [Related]
37. Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
Overturf ML; Smith SA
Artery; 1986; 13(5):267-82. PubMed ID: 3527114
[TBL] [Abstract][Full Text] [Related]
38. Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.
Cai W; Ruan LM; Wang YN; Chen JZ
J Zhejiang Univ Sci B; 2006 Aug; 7(8):648-53. PubMed ID: 16845719
[TBL] [Abstract][Full Text] [Related]
39. Decreased infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the anti-atherogenic effects of losartan.
Xu HX; Li JJ; Li GS; Wang J; Li NX; Peng J
Acta Cardiol; 2007 Dec; 62(6):607-13. PubMed ID: 18214127
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.
Strawn WB; Chappell MC; Dean RH; Kivlighn S; Ferrario CM
Circulation; 2000 Apr; 101(13):1586-93. PubMed ID: 10747353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
